TCG Crossover Management’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,163,356
| Closed | -$13.8M | – | 34 |
|
|
2024
Q1 | $13.8M | Sell |
1,163,356
-2,232,139
| -66% | -$26.5M | 1.09% | 26 |
|
|
2023
Q4 | $41.6M | Hold |
3,395,495
| – | – | 4.61% | 11 |
|
|
2023
Q3 | $32.7M | Hold |
3,395,495
| – | – | 4.81% | 7 |
|
|
2023
Q2 | $30.6M | Hold |
3,395,495
| – | – | 5.01% | 9 |
|
|
2023
Q1 | $26.7M | Hold |
3,395,495
| – | – | 5.2% | 7 |
|
|
2022
Q4 | $23M | Buy |
+3,395,495
| New | +$23M | 4.05% | 10 |
|